Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ikerian
Bern, Bern, Switzerlandikerian.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Ikerian’s Discovery platform is CE-marked and FDA-cleared for certain applications. It is deployed in clinics and pharma settings globally, supporting real-time analysis of multimodal healthcare data with AI-driven insights. The company has processed over 20 clinical studies and more than 1 million patient images, with over 40 peer-reviewed publications validating its technology[1][2][5].
- Therapeutic areas
- Rare DiseasesCardiovascularOphthalmologyNeurology
- Modalities
- Software platform (Discovery)Artificial intelligenceMachine learning
- Industry
- Medical Imaging
02
Partnerships
Beyond the preview
Go deeper on Ikerian.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ikerian.